Targets and emerging therapies for schizophrenia

Saved in:
Bibliographic Details
Corporate Author: ebrary, Inc
Other Authors: Albert, Jeffrey S., Wood, Michael W. (Michael William), 1961-
Format: Electronic eBook
Language:English
Published: Hoboken, N.J. : Wiley, 2012.
Subjects:
Online Access:An electronic book accessible through the World Wide Web; click to view
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000 a 4500
001 0000152330
005 20171002062411.0
006 m u
007 cr cn|||||||||
008 111222s2012 njuaf sb 001 0 eng d
010 |z  2011051091 
020 |z 9780470322826 (cloth) 
020 |z 9781118309384 (e-book) 
035 |a (CaPaEBR)ebr10580248 
035 |a (OCoLC)769289644 
040 |a CaPaEBR  |c CaPaEBR 
050 1 4 |a RC514  |b .T37 2012eb 
082 0 4 |a 616.89/8061  |2 23 
245 0 0 |a Targets and emerging therapies for schizophrenia  |h [electronic resource] /  |c edited by Jeffrey S. Albert, Michael W. Wood. 
260 |a Hoboken, N.J. :  |b Wiley,  |c 2012. 
300 |a xiii, 472 p., [4] p. of col. plates :  |b ill. 
504 |a Includes bibliographical references and index. 
505 0 |a Dopaminergic hypothesis of schizophrenia : a historical perspective / Aurelija Jucaite and Svante Nyberg -- Dopamine D2/D3 partial agonists as antipsychotics / Philip G. Strange -- D1/D5 dopamine agonists as pharmacotherapy for schizophrenia / Kevin N. Boyd and Richard B. Mailman -- PDE inhibitors as a novel therapeutic approach for schizophrenia / Judith A. Siuciak and William J. Pitts -- Glutamatergic synaptic dysregulation in schizophrenia / Joseph T. Coyle, Alo Basu, and Michael Benneyworth -- Metabotropic glutamate 2/3 receptor agonists and positive allosteric modulators of metabotropic glutamate receptor 2 as novel agents for the treatment of schizophrenia / Gerard J. Marek ... [et al.] -- AMPA receptor positive modulators / John A. Morrow, John K.F. Maclean, and Craig Jamieson -- Progress in the exploration and development of GlyT1 inhibitors for schizophrenia / Jeffrey S. Albert and Michael W. Wood -- Combined dopamine D2 and 5-hydroxytryptamine (5-HT)1a receptor strategies for the treatment of schizophrenia, a pharmacological and chemical perspective / Andrew C. Mccreary, Roelof W. Feenstra, and Caitlin A. Jones -- 5-HT2C and 5-HT6 receptor targeted emerging approaches in schizophrenia / Sharon Rosenzweig-Lipson ... [et al.] -- The cholinergic hypothesis : an introduction to the hypothesis and a short history / Joseph I. Friedman, Isabella Kanellopoulou, and Vladan Novakovic -- À7 nicotinic acetylcholine receptors in the treatment of schizophrenia / Mihály Hajós, and Bruce N. Rogers -- Muscarinic acetylcholine receptors as novel targets for the development of therapeutics for schizophrenia / Christian C. Felder ... [et al.] -- Will modulation of neuropeptide receptors produce the next generation of antipsychotic drugs? : a focus on the neurokinin and neurotensin systems / Lee A. Dawson, Paul W. Smith, and Jeannette M. Watson -- GABA and schizophrenia / John H. Kehne and George D. Maynard. 
533 |a Electronic reproduction.  |b Palo Alto, Calif. :  |c ebrary,  |d 2011.  |n Available via World Wide Web.  |n Access may be limited to ebrary affiliated libraries. 
650 0 |a Schizophrenia  |x Treatment. 
655 7 |a Electronic books.  |2 local 
700 1 |a Albert, Jeffrey S. 
700 1 |a Wood, Michael W.  |q (Michael William),  |d 1961- 
710 2 |a ebrary, Inc. 
856 4 0 |u http://site.ebrary.com/lib/daystar/Doc?id=10580248  |z An electronic book accessible through the World Wide Web; click to view 
908 |a 170314 
942 0 0 |c EB 
999 |c 141478  |d 141478